Vaccine Advancement, Efficacy and Safety
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims
The aim of the Section “Vaccine Advancement, Efficacy, and Safety” is to examine the methods and strategies of vaccine advancement, as well as the features and attributes of how vaccination protects people against infection, symptomatic illness, hospitalization, and mortality.
Scope
Vaccines are among the most effective, safe, and cost-effective health interventions. Vaccine advancements have focused on increasing vaccine immunogenicity, efficacy, effectiveness, safety, accessibility, acceptability, and efficiency. Articles addressing adjuvants that produce a robust and longer-lasting immune response to a vaccine, as well as vaccine optimization strategies that enhance efficacy and safety, are encouraged. Topics may include advancements in vaccine design and development against infectious diseases, cancer vaccines, and vaccines against other non-transmissible diseases. Advancements in vaccine efficiency can be demonstrated in economic and cost-effectiveness studies. Personalized vaccines can be developed against a specific individual's cancer. We invite submissions addressing preclinical and clinical studies, and encourage translational research that bridges experimental findings with human applications. We will consider original research articles, brief reports, reviews, and others relevant article types.
Keywords
- vaccine advancement
- immunogenicity
- vaccine efficacy
- vaccine effectiveness
- vaccine efficiency
- vaccine access
- vaccine acceptability
- vaccine safety
- vaccine design
- vaccine platforms
- adjuvants
- personalized vaccines
- evaluative studies
- cost-effectiveness of vaccines
- post-marketing studies
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Promoting Research, Development and Access to Vaccines to Address Global Inequities (Deadline: 31 October 2025)
- New Approaches to Vaccine Development and Delivery (Deadline: 31 October 2025)
- Vaccine Efficacy and Safety in Transplant Recipients (Deadline: 31 October 2025)
- Vaccine Efficacy and Safety in Patients with Immune-Mediated Intestinal Diseases (Deadline: 30 November 2025)
- Evaluation of Vaccine Efficacy, Safety and Immunogenicity Against Influenza, RSV and COVID-19 (Deadline: 31 December 2025)
- Effectiveness and Safety of Vaccines in Special Populations (Deadline: 31 January 2026)
- Safety and Side Effects in SARS-CoV-2 Vaccine (Deadline: 28 February 2026)
- Advancements in Vaccine Research: Epidemiology, Immunogenicity, Effectiveness and Safety (Deadline: 20 March 2026)
- Clinical Strategies to Improve Efficacy, Effectiveness, and Safety of Vaccination in Humans (Deadline: 31 May 2026)
- Safety and Immunogenicity of Vaccination (Deadline: 31 May 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
